Robert McWhirter
Algernon Pharmaceuticals Inc.
AGN-X
HOLD
May 29, 2020
It produces a drug that has been repurposed for anti-anxiety in Japan. When you look at COVID-19 and its related illnesses, the drug can be used to help with chronic cough and pneumonia. Their chronic cough trial is going into Phase II in Australia. He owns it personally.